Edwards Lifesciences Announces CFO Retirement
IRVINE, CA -- (Marketwired) -- 05/14/13 -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in the science of heart
valves and hemodynamic monitoring, today announced that Thomas M.
Abate, the company's chief financial officer, plans to retire later
this year. Abate, who turns 60 in August, plans to remain CFO until
his successor is in place. The company has retained Peter Crist of
Crist/Kolder Associates to assist in the CFO search.
"Tom has had a very productive 31-year career with our company, and I
want to thank him for his many significant contributions to our
success," said Michael A. Mussallem, Edwards' chairman and CEO. "Tom
played an important role in establishing Edwards as a standalone
company following our spinoff from Baxter Healthcare Corporation in
2000. He has been a valuable business partner and has been
instrumental in helping us adapt to an evolving financial landscape,
while also positioning the company for the future. His dedication to
Edwards has been exemplary, and we look forward to his continued
leadership through this transition."
Abate became Edwards' CFO in January 2006. Previously, he was the
company's vice president and controller, a position he had held since
Edwards became an independent company. In the 18 years prior, Abate
was with Baxter in other finance-related positions.
About Edwards Lifesciences
Edwards Lifesciences is the global leader
in the science of heart valves and hemodynamic monitoring. Driven by
a passion to help patients, the company partners with clinicians to
develop innovative technologies in the areas of structural heart
disease and critical care monitoring, enabling them to save and
enhance lives. Additional company information can be found at
Edwards, Edwards Lifesciences and the stylized E logo are trademarks
of Edwards Lifesciences Corporation.
David K. Erickson
Press spacebar to pause and continue. Press esc to stop.